NUGALVIQ & Design

Trademark usage description

pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 14

Dotted lines or bandsLignes ou bandes pointillées

Classification Information

Class [005]
Pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; pharmaceutical preparations for inhibiting aldose reductase; pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)

Classification kind code

Mark Details

Serial Number

2140735

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 29^th Nov 2024	Search Recorded
Submitted for opposition 20 on 29^th Nov 2024	Examiner's First Report
Submitted for opposition 67 on 27^th Sept 2024	Agent Name Changed
Submitted for opposition 287 on 11^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 18^th Oct 2021	Filed
Submitted for opposition 1 on 18^th Oct 2021	Created
Submitted for opposition 31 on 18^th Oct 2021	Formalized